← All organizations

Esanex Inc.

For profit

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 2

First clinical trial

Last known activity

Feb 7, 2017

Defunct as of Jan 18, 2013

Timeline

2010s

Jun 1, 2011
Esanex Inc.— Founded
Jan 18, 2013
Esanex Inc.— Defunct

Drugs by trial phase (2 distinct, 12 trials)

Phase 2 (1 own, 0 via acquisition)

snx-5422

Phase 1 (1 own, 0 via acquisition)

ibrutinib

Indications

Studied for

Recent trials (12)

NCT02973399Lead sponsorPhase 1Feb 7, 2017
NCT02914327Lead sponsorPhase 1Feb 2, 2017
NCT02612285Lead sponsorPhase 2Mar 1, 2016
NCT02063958Lead sponsorPhase 1Feb 1, 2014
NCT01635712Lead sponsorPhase 1Feb 1, 2014
NCT01892046Lead sponsorPhase 1Nov 1, 2013
NCT01848756Lead sponsorPhase 1/Phase 2Apr 1, 2013
NCT01851096Lead sponsorPhase 1Mar 1, 2013
NCT01611623Lead sponsorPhase 1May 1, 2012
NCT00647764Lead sponsorPhase 1Mar 1, 2008
NCT00595686Lead sponsorPhase 1Jan 1, 2008
NCT00506805Lead sponsorPhase 1Jun 1, 2007

Details

Founded: Indianapolis, IN, US Jun 1, 2011
Last known activity: Feb 7, 2017